Francis Buadi Selected Research

Francis Buadi Research Topics

Disease

26	Multiple Myeloma 01/2023 - 07/2009
9	Immunoglobulin Light-chain Amyloidosis 01/2021 - 06/2012
8	Amyloidosis 01/2021 - 01/2008
6	POEMS Syndrome (Syndrome, POEMS) 09/2013 - 05/2008
3	Paraproteinemias (Monoclonal Gammopathy) 01/2018 - 10/2011
3	Peripheral Nervous System Diseases (PNS Diseases) 04/2015 - 05/2008
2	Neoplasms (Cancer) 01/2022 - 12/2016
2	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 09/2012
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 05/2017
2	Disease Progression 01/2021 - 06/2015
2	Thrombocytosis (Thrombocythemia) 01/2018 - 05/2008
2	Polyradiculoneuropathy (Polyradiculoneuritis) 09/2013 - 07/2012
1	Vesicular Stomatitis 01/2022
1	Bacteremia 01/2021
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2021
1	Hydronephrosis 01/2021
1	Intestinal Perforation 12/2020
1	Nemaline Myopathies (Nemaline Myopathy) 01/2019
1	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 01/2018
1	Lymphoma (Lymphomas) 05/2017
1	Plasma Cell Neoplasms 09/2013
1	Rare Diseases (Rare Disease) 07/2012
1	Pain (Aches) 06/2010
1	Renal Insufficiency (Renal Failure) 06/2010
1	Papilledema 05/2008
1	Neurolymphomatosis 06/2004

Drug/Important Bio-Agent (IBA)

9	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 07/2009
8	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2008
6	Lenalidomide (CC 5013)FDA Link 01/2021 - 07/2009
4	Thalidomide (Thalomid)FDA Link 04/2015 - 10/2009
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 04/2015
3	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 06/2014 - 06/2012
3	pomalidomideIBA 06/2012 - 10/2009
2	Bortezomib (Velcade)FDA Link 01/2021 - 11/2016
2	carfilzomibIBA 04/2015 - 10/2012
2	Melphalan (Alkeran)FDA LinkGeneric 09/2012 - 06/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2011 - 05/2008
2	Immunomodulating AgentsIBA 08/2011 - 10/2009
2	Immunoglobulins (Immunoglobulin)IBA 06/2010 - 11/2008
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	InterferonsIBA 01/2022
1	sodium-iodide symporter (sodium iodide symporter)IBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	plerixafor FDA Link 01/2021
1	Factor XII (Hageman Factor)IBA 01/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021
1	Factor VII (Proconvertin)IBA 01/2021
1	Nerve Growth Factor (NGF)IBA 01/2021
1	Factor V (Coagulation Factor V)IBA 01/2021
1	SteroidsIBA 12/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	daratumumabIBA 01/2019
1	Rituximab (Mabthera)FDA Link 05/2017
1	Interferon Type IIBA 12/2016
1	LCL161IBA 12/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2016
1	ixazomibIBA 11/2016
1	thiamine triphosphorate (TTP)IBA 06/2015
1	Interleukin-10 (Interleukin 10)IBA 09/2013
1	Interleukin-4 (Interleukin 4)IBA 09/2013
1	CytokinesIBA 09/2013
1	Epidermal Growth Factor (EGF)IBA 09/2013
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 09/2013
1	Interleukin-13IBA 09/2013
1	Insulin (Novolin)FDA Link 11/2012
1	Proteasome InhibitorsIBA 10/2012
1	Immunoglobulin A (IgA)IBA 06/2010
1	samarium Sm-153 lexidronam (Quadramet)FDA Link 06/2010
1	RadiopharmaceuticalsIBA 06/2010
1	Cystatin CIBA 06/2010
1	Immunoglobulin G (IgG)IBA 06/2010
1	VaccinesIBA 12/2009
1	Troponin T (Troponin T1)IBA 01/2008
1	Methotrexate (Mexate)FDA LinkGeneric 06/2004

Therapy/Procedure

15	Therapeutics 01/2023 - 06/2004
14	Stem Cell Transplantation 01/2022 - 06/2004
2	Transplantation 01/2023 - 09/2013
2	Drug Therapy (Chemotherapy) 01/2021 - 05/2013
1	Hematopoietic Stem Cell Mobilization 01/2021
1	Stents 01/2021
1	Nephrotomy 01/2021
1	Immunomodulation 01/2018
1	Hematopoietic Stem Cell Transplantation 09/2012
1	Retreatment 08/2011
1	Autologous Transplantation 12/2009